{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"44","upperLimit":"67","value":"57"},{"groupId":"OG001","lowerLimit":"56","upperLimit":"79","value":"69"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"85"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Observation (+/- Radiation). Patients receive radiotherapy\\* within 6 months after surgery.\n\nradiation therapy: Given within 6 months after surgery","id":"OG000","title":"Arm I"},{"description":"Chemotherapy (+/- Radiation). Within 10 weeks after surgery, patients receive at least 3 courses of an adjuvant chemotherapy regimen as determined by the investigator. Patients may receive radiotherapy within 6 months after surgery and after the completion of chemotherapy OR integrated with chemotherapy.\n\nchemotherapy: Given within 10 weeks after surgery.","id":"OG001","title":"Arm II"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"5 years after randomization","title":"Disease-free Survival","type":"PRIMARY","unitOfMeasure":"percentage of participants"}